Author/Authors :
Saedi, Samaneh Department of Bacteriology - Pasteur Institute of Iran, Tehran, Iran , Safarchi, Azadeh Department of Bacteriology - Pasteur Institute of Iran, Tehran, Iran , Tayebzadeh Moghadam, Faranak Department of Bacteriology - Pasteur Institute of Iran, Tehran, Iran , Heidarzadeh, Siamak Department of Microbiology and Virology - School of Medicine -Zanjan University of Medical Sciences, Zanjan, Iran , Sadat Nikbin, Vajihe Department of Bacteriology - Pasteur Institute of Iran, Tehran, Iran , Shahcheraghi, Fereshteh Pertussis Reference Laboratory - Department of Bacteriology - Pasteur Institute of Iran, Tehran, Iran
Abstract :
Bordetella pertussis, a highly contagious respiratory. Notably, the resurgence of pertussis has recent-ly been associated with the lacking production of vaccine virulence factors. This study aimed to screen pertactin (Prn) and filamentous hemagglutinin (Fha) production in Iran with 50 years' whole cell vaccine (WCV) immun-ization program.
Methods: Overall, 130 B. pertussis isolates collected from Pertussis Reference Laboratory of Iran during 2005-2018. Real-time PCR was performed by targeting IS481, ptxP, IS1001 and IS1002 for species confirmation of B. pertussis. Western-blot was used to evaluate the expression of virulence factors (pertactin and filamentous he-magglutinin).
Results: All tested B. pertussis isolates expressed Prn and all except two isolates expressed Fha. We have se-quenced genomes of these strains and identified differences compared with genome reference B. pertussis To-hama I.
Conclusion: Many countries reporting Prn and Fha-deficiency due to acellular vaccine (ACV) pressure. Our results demonstrate in a country with WCV history, Fha-deficient isolates may rise independently. However, Prn-deficient isolates are more under the ACV pressure in B. pertussis isolates. Continues surveillance will pro-vide a better understanding of the effect of WCV on the evolution of the pathogen deficiency
Keywords :
Whooping cough , Pertactin , Filamentous hemagglutinin , Whole-cell vaccine , Iran , Bordetella pertussis